Cingulate

Cingulate Net Tangible Assets

The Net Tangible Assets of Cingulate (CING) as of Nov 5, 2026 is 2.51 M USD. In the previous year, Net Tangible Assets was 7.46 M USD — a change of -66.35% (lower).

Net Tangible Assets

2.51 MUSD

YoY

-66.35%

Last updated:

Net Tangible Assets of Cingulate is 2025 2.51 M USD. Net Tangible Assets of Cingulate was 2024 7.46 M USD. It decreases by -66.35% lower compared to the previous year.

The Cingulate Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2019
615,880.00 USD
Jan 1, 2020
1.29 M USD
Jan 1, 2021
20.84 M USD
Jan 1, 2022
3.88 M USD
Jan 1, 2023
-6.87 M USD
Jan 1, 2024
7.46 M USD
Jan 1, 2025
2.51 M USD
The Cingulate Net Tangible Assets history
YEARNet Tangible AssetsYoY
2.51 MUSD-66.35%
7.46 MUSD-208.53%
-6.87 MUSD-276.95%
3.88 MUSD-81.38%
20.84 MUSD+1,512.73%
1.29 MUSD+109.85%
615,880.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cingulate Stock analysis

What does Cingulate do? Cingulate Inc is a US-based biopharmaceutical company headquartered in Kansas City, Kansas, that focuses on the development, manufacturing, and commercialization of pharmaceutical products. The firm utilizes its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles designed to improve the lives of patients suffering from commonly diagnosed conditions. The company specifically targets the treatment of attention deficit/hyperactivity disorder (ADHD) through its innovative approach to drug delivery. The firm is currently developing two lead product candidates, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). These drug candidates both contain three releases of an active pharmaceutical ingredient combined into one small tablet dosage form. By employing this technology, Cingulate Inc aims to provide effective treatment options for ADHD across three core patient segments: children aged 6-12, adolescents aged 13-17, and adults aged 18 and older. Cingulate is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cingulate stock

Net Tangible Assets of Cingulate is 2.51 M USD in 2025.

Net Tangible Assets of Cingulate changed from 7.46 M USD to 2.51 M USD, representing a -66.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Cingulate since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Cingulate historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cingulate

All Key Metrics — Cingulate